JPRN-UMIN000031216
Completed
Phase 4
A Prospective, Multicenter, Observational Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated with Ixazomib plus Lenalidomide and Dexamethasone - A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated with Ixazomib plus Lenalidomide and Dexamethasone
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Relapsed and/or Refractory Multiple Myeloma
- Sponsor
- Takeda Pharmaceutical Company Limited
- Enrollment
- 300
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Female patients who are nursing or pregnant 2\. Patients who have been treated with ixazomib 3\. Patients with hypersensitivity to any of the components of IRd therapy, their analogs or excipients 4\. Patients with another active malignancy, i.e. synchronous active malignancy or previous malignancy with a disease\-free period of less than 5 years, except for patients with carcinoma in situ (intraepithelial carcinoma) or intramucosal carcinoma judged to be cured by topical treatment 5\. Patients who are not registered with, or comply with, the guidelines of the lenalidomide management program 6\. Patients who, in the judgement of the principal investigator or investigator(s), are considered to be unsuitable for enrolment into the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A Clinical Study of the Efficacy and Safety of Corticosteroids for Cancer-induced Neuropathic Pain.Cancer painJPRN-UMIN000040584Tohoku University Graduate School of Medicine200
Completed
Not Applicable
Impact of OCT guided imaging in decision making in PCIHealth Condition 1: I251- Atherosclerotic heart disease of native coronary arteryCTRI/2018/10/015872isie Hospital500
Recruiting
Not Applicable
Polatuzumab vedotin plus R-CHP therapy in patients with previously untreated diffuse large B-cell lymphomaDiffuse large B-cell lymphomDLBCLDLBCJPRN-jRCT1071220082Kato Koji500
Not yet recruiting
Phase 4
An Observational study to evaluate the safety and effectiveness of Rejoint Max® in Indian Patients with Osteoarthritis of KneeHealth Condition 1: M170- Bilateral primary osteoarthritis of kneeCTRI/2020/03/023852Abbott Healthcare Pvt Ltd
Recruiting
Not Applicable
Study of Bifurcation Coronary Stenting in IndiaCTRI/2020/08/027411Cardiovascular Research Society Kerala